Julian Steffenhagen

Julian Steffenhagen discloses dealings in 2 companies, chiefly Beckman Coulter Inc and Hemacare Corp /CA/. Over a trading history stretching from 11 April 2006 to 14 September 2011, the count stands at 120 filings.

The open-market side counts 1 purchase for €10k alongside 112 sales for €1.4M. The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants and 5 option exercises. In 2011 alone, the filings show 1 purchase and no sales.

On 23 September 2011 came the latest disclosure, an open-market purchase for €10k in Hemacare Corp /CA/. Filings reach the SEC (Form 4) feed a median of 8 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.